IGC Pharma (IGC) SEC Filings & 10K Form $0.30 -0.03 (-9.23%) Closing price 03/28/2025 03:59 PM EasternExtended Trading$0.29 0.00 (-1.01%) As of 03/28/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesOwnershipSEC FilingsBuy This Stock Recent IGC Pharma SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView09/27/20243:05 PMIGC Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 09/27/20243:05 PMIGC Pharma (Issuer)Moran James P (Reporting)Form 4Statement of changes in beneficial ownership of securities 08/14/20243:23 PMBradbury Strategic Investment Fund A (0002022777) (Filed by)IGC Pharma (Subject)Form SC 13D/A08/12/20248:26 AMIGC Pharma (Issuer)PRINS RICHARD K (Reporting)Form 4Statement of changes in beneficial ownership of securities 08/09/20245:03 PMIGC Pharma (Subject)PRINS RICHARD K (Reporting)Form 144Notice of proposed sale of securities pursuant to Rule 144 08/02/20241:38 PMIGC Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 07/09/20241:17 PMIGC Pharma (Filer)Form DEFA14A06/24/202412:32 PMIGC Pharma (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 05/21/20248:20 PMBradbury Strategic Investment Fund A (0002022777) (Filed by)IGC Pharma (Subject)Form SC 13D05/13/20248:53 PMBradbury Strategic Investment Fund A (0002022777) (Reporting)IGC Pharma (Issuer)Form 3Initial statement of beneficial ownership of securities 05/13/20248:54 PMBradbury Strategic Investment Fund A (0002022777) (Reporting)IGC Pharma (Issuer)Form 4Statement of changes in beneficial ownership of securities 05/02/202411:15 PMIGC Pharma (Filer)Form EFFECT04/05/202410:33 AMIGC Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Remove Ads Related Companies and Tools Related Companies Kyverna Therapeutics SEC Filings Biomea Fusion SEC Filings Black Diamond Therapeutics SEC Filings Jaguar Health SEC Filings Pliant Therapeutics SEC Filings Ventyx Biosciences SEC Filings Zomedica SEC Filings Artiva Biotherapeutics SEC Filings Caribou Biosciences SEC Filings InflaRx SEC Filings SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NYSEMKT:IGC) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredCrypto Genius: 12,000% in 12 months? [Here’s how]We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredForget Trump’s Tariffs, This March Event Is BiggerWhile everyone is distracted by Trump’s tariffs and a potential trade war… There’s something much bigger ha...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IGC Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IGC Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
